Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

This Blue-Chip Stock Is a Heavy Weight in Weight-Loss Drugs

  • Eli Lilly (LLY) stands out for its diversified pharmaceutical portfolio, robust pipeline, and strategic acquisitions that are fueling growth.
  • LLY has strong technical momentum and is trading at new all-time highs.
  • Shares are up 43% over the past year.
  • Analyst sentiment is overwhelmingly positive, with most major firms rating LLY a “Buy.” 

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.